-+ 0.00%
-+ 0.00%
-+ 0.00%

Johns Hopkins Medicine Initiates Enrollment For RenovoRx's Ongoing Phase III TIGeR-PaC Clinical Trial

Benzinga·04/29/2025 12:37:33
Listen to the news

Johns Hopkins Medicine's Valerie Lee, MD joins Michael J. Pishvaian, MD in an Appointed Key Role for TIGeR-PaC Trial

By becoming an additional clinical site for TIGeR-PaC, Johns Hopkins Medicine joins several esteemed cancer centers to support RenovoRx's initiative to complete patient enrollment for the trial during 2025